PMID- 21704607 OWN - NLM STAT- MEDLINE DCOM- 20120809 LR - 20171116 IS - 1873-3492 (Electronic) IS - 0009-8981 (Linking) VI - 412 IP - 19-20 DP - 2011 Sep 18 TI - Persistent elevation of paraoxonase-1 specific enzyme activity after weight reduction in obese non-diabetic men with metabolic syndrome. PG - 1835-41 LID - 10.1016/j.cca.2011.06.018 [doi] AB - BACKGROUND: Paraoxonase-1 (PON1) is an esterase associated with the high-density lipoprotein (HDL) in serum. To date, there have been few reports about circulating PON1 protein concentration and specific activity in subjects with metabolic syndrome (MetS). More importantly, it is unknown whether weight loss could alter PON1 protein expression or specific activity in obese non-diabetic men with MetS. METHODS: We prospectively enrolled a total of 40 obese non-diabetic men with MetS. Among them, 22 subjects finished the 3-month course of weight loss program and complied for longer follow-ups post-weight loss at the 3rd, 12th, and 18th month from the beginning of the program. Twenty-six healthy volunteers served as controls. Serum circulating PON1 concentration was measured by an enzyme linked immunosorbent kit (ELISA) and PON1 activity was measured by an automated PON1 activity assay. RESULTS: Obese non-diabetic men with MetS (n=40) had a higher PON1 protein concentration (31.0 +/- 11.3 vs. 24.8 +/- 9.7 mug/ml, p=0.025) but lower specific enzyme activity (7.5 +/- 4.0 vs. 11.2 +/- 7.2 mU/mug, p=0.023) than those of the controls. Multivariate regression analysis of baseline PON1 specific activity revealed that adiponectin was a significant positive predictor (p=0.044) while monocyte chemotactic protein-1 (MCP-1) was a negative predictor (p=0.031). After a 3-month weight loss program, obese MetS men (n=22) had a significant weight reduction (95.8 +/- 9.0 to 86.3 +/- 10.4 kg, with a 9.9 +/- 5.4% decrease, p<0.001). PON1 protein decreased significantly after weight loss and kept declining through the 3rd month till the 18th month follow-up. PON1 specific enzyme activity (baseline 7.5 +/- 2.6 mU/mug) increased significantly after weight loss and kept increasing through the 12th month till the 18th month follow-ups (11.8 +/- 6.4 mU/mug, p=0.001 vs. baseline). CONCLUSIONS: Weight loss by a 3-month diet and exercise program time-sequentially increased PON1 specific enzyme activity in obese non-diabetic men with MetS. CI - Copyright (c) 2011 Elsevier B.V. All rights reserved. FAU - Liang, Kae-Woei AU - Liang KW AD - Cardiovascular Center, Taichung Veterans General Hospital, Taiwan. FAU - Lee, Wen-Jane AU - Lee WJ FAU - Lee, I-Te AU - Lee IT FAU - Lee, Wen-Lieng AU - Lee WL FAU - Lin, Shih-Yi AU - Lin SY FAU - Hsu, Shih-Lan AU - Hsu SL FAU - Wan, Chu-Jen AU - Wan CJ FAU - Yu, Chen-Yuan AU - Yu CY FAU - Tsai, I-Chen AU - Tsai IC FAU - Fu, Chia-Po AU - Fu CP FAU - Ting, Chih-Tai AU - Ting CT FAU - Sheu, Wayne H-H AU - Sheu WH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110617 PL - Netherlands TA - Clin Chim Acta JT - Clinica chimica acta; international journal of clinical chemistry JID - 1302422 RN - EC 3.1.8.1 (Aryldialkylphosphatase) SB - IM MH - Adult MH - Aryldialkylphosphatase/*metabolism MH - Humans MH - Male MH - Metabolic Syndrome/complications/*enzymology/physiopathology MH - Middle Aged MH - Obesity/complications/*enzymology/physiopathology MH - Prospective Studies MH - *Weight Loss EDAT- 2011/06/28 06:00 MHDA- 2012/08/10 06:00 CRDT- 2011/06/28 06:00 PHST- 2011/01/13 00:00 [received] PHST- 2011/06/13 00:00 [revised] PHST- 2011/06/13 00:00 [accepted] PHST- 2011/06/28 06:00 [entrez] PHST- 2011/06/28 06:00 [pubmed] PHST- 2012/08/10 06:00 [medline] AID - S0009-8981(11)00351-2 [pii] AID - 10.1016/j.cca.2011.06.018 [doi] PST - ppublish SO - Clin Chim Acta. 2011 Sep 18;412(19-20):1835-41. doi: 10.1016/j.cca.2011.06.018. Epub 2011 Jun 17.